Simulations Plus, Inc. (NASDAQ:SLP) is set to announce third quarter earning results on Thursday 9th July 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, SLP to report 3Q20 income of $ 0.09 per share from revenue of $ 11.21 million.
For the full year, analysts anticipate top line of $ 39.86 million, while looking forward to income of $ 0.38 per share bottom line.
Stock Performance
According to the previous trading day, closing price of SLP was $ 61.83, representing a 137.81 % increase from the 52 week low of $ 26.00 and a 2.52 % decrease over the 52 week high of $ 63.43.
The company has a market capital of $ 1.10 billion and is part of the Technology sector and Health Information Services industry.
Recent Stock Dividend Announcement
The board of directors has authorized quarterly dividend of $ 0.06 per share on April 9, 2020. The dividend were payable on May 1, 2020 to holders of record as of the close of business on April 24, 2020 and ex-dividend date on April 23, 2020.
Conference Call
Simulations Plus, Inc. will be hosting a conference call at 4:15 PM eastern time on 9th July 2020, to discuss its 3Q20 financial results with the investment community. The participants may dial, (562) 247-8422 in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website register.gotowebinar.com/register/8460226712731878158
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
